ＥＺＨ２発現の調節因子 - Ionis Pharmaceuticals,Inc.

Title:

ＥＺＨ２発現の調節因子

Document Type and Number:

Japanese Patent JP7275164

Kind Code:

B2

Abstract:

The present embodiments provide methods, compounds, and compositions useful for inhibiting EZH2 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with EZH2.

More Like This:

WO/2005/086825	METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH ABERRANT MICROSATELLITE EXPANSION
WO/2017/099823	COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS
JP2023548658	Selective delivery of oligonucleotides to glial cells

Inventors:

Joe, Minji
Kim, Youngsu
Macleod, Robert
Flair, Susan M

Application Number:

JP2020555340A

Publication Date:

May 17, 2023

Filing Date:

April 11, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Ionis Pharmaceuticals,Inc.

International Classes:

C12N15/113; A61K31/7115; A61K31/712; A61K31/7125; A61P35/00; A61P35/02

Domestic Patent References:

JP2004217634A

Attorney, Agent or Firm:

Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Kenji Takeda

Previous Patent: Use of Coriobacteria to Promote Gastrointestinal Health

Next Patent: Omnidirectional optical measurement device